Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q1 2022

Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.

Institution overview
Positions
49
0 vs. Q4 2021
Portfolio value
$1.55B
+$194.9M (+14.4%) vs. Q4 2021
Filed
May 16, 2022
SEC
Holdings of Deep Track Capital, LP in Q1 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
NVCRNovoCure LtdORD SHS1,000,000$82.8M5.4%+450,000+81.8%AddedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS1,855,993$81.4M5.3%+755,993+68.7%AddedHistory
TVTXTravere Therapeutics, Inc.COM3,134,503$80.8M5.2%+684,503+27.9%AddedHistory
JAZZJazz Pharmaceuticals plcSHS USD517,051$80.5M5.2%+17,051+3.4%AddedHistory
GBTGlobal Blood Therapeutics, Inc.COM2,304,683$79.8M5.2%+304,683+15.2%AddedHistory
FATEFate Therapeutics IncCOM2,000,000$77.5M5.0%+1,581,963+378.4%AddedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM786,000$77.1M5.0%+286,000+57.2%AddedHistory
ISEEIVERIC bio, Inc.COM4,500,000$75.7M4.9%+500,000+12.5%AddedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM463,663$75.7M4.9%+463,663NewHistory
KROSKeros Therapeutics, Inc.COM1,380,306$75.1M4.8%+80,306+6.2%AddedHistory
KURAKura Oncology, Inc.COM3,412,000$54.9M3.5%+862,000+33.8%AddedHistory
KDNYChinook Therapeutics, Inc.COM3,000,000$49.1M3.2%+579,498+23.9%AddedHistory
BEAMBeam Therapeutics Inc.COM763,750$43.8M2.8%+63,750+9.1%AddedHistory
IMVTImmunovant, Inc.COM7,224,613$39.8M2.6%+2,449,613+51.3%AddedHistory
RPTXRepare Therapeutics Inc.COM2,664,017$37.9M2.5%+564,017+26.9%AddedHistory
FDMT4D Molecular Therapeutics, Inc.COM2,448,200$37.0M2.4%+548,200+28.9%AddedHistory
AGENAgenus IncCOM NEW13,998,491$34.4M2.2%+13,998,491NewHistory
CRNXCrinetics Pharmaceuticals, Inc.COM1,541,715$33.8M2.2%−358,285−18.9%ReducedHistory
DYNDyne Therapeutics, Inc.COM3,500,000$33.7M2.2%+1,207,750+52.7%AddedHistory
JNCEJounce Therapeutics, Inc.COM4,259,653$28.9M1.9%+259,653+6.5%AddedHistory
ESPREsperion Therapeutics, Inc.COM6,000,000$27.8M1.8%+358,332+6.4%AddedHistory
KALVKalVista Pharmaceuticals, Inc.COM1,729,757$25.5M1.6%+229,757+15.3%AddedHistory
NKTXNkarta, Inc.COM2,113,795$24.1M1.6%+849,369+67.2%AddedHistory
DICEDICE Therapeutics, Inc.COM1,250,000$23.9M1.5%−91,004−6.8%ReducedHistory
SAGESage Therapeutics, Inc.COM675,000$22.3M1.4%+175,000+35.0%AddedHistory
TCDATricida, Inc.COM2,652,693$21.8M1.4%+317,550+13.6%AddedHistory
VRDNViridian Therapeutics, Inc.COM1,170,290$21.6M1.4%−166,400−12.4%ReducedHistory
SLNSilence Therapeutics plcADS951,580$18.1M1.2%+782+0.1%AddedHistory
DNTHDianthus Therapeutics, Inc.COM5,359,000$15.5M1.0%+489,000+10.0%AddedHistory
FMTXForma Therapeutics Holdings, Inc.SHS1,659,706$15.4M1.0%+1,659,706NewHistory
FULCFulcrum Therapeutics, Inc.COM650,000$15.4M1.0%−100,000−13.3%ReducedHistory
ENTAEnanta Pharmaceuticals IncCOM198,730$14.1M0.9%+198,730NewHistory
ANABAnaptysbio, IncCOM558,782$13.8M0.9%+558,782NewHistory
GRTSGritstone bio, Inc.COM2,985,729$12.3M0.8%+1,213,928+68.5%AddedHistory
IPSCCentury Therapeutics, Inc.COM926,469$11.7M0.8%+676,469+270.6%AddedHistory
HOOKHOOKIPA Pharma Inc.COM5,035,998$11.5M0.7%+5,035,998NewHistory
PASGPassage BIO, Inc.COM3,375,000$10.5M0.7%+158,003+4.9%AddedHistory
ABOSAcumen Pharmaceuticals, Inc.COM2,599,098$10.2M0.7%+666,058+34.5%AddedHistory
RXDXPrometheus Biosciences, Inc.COM245,000$9.25M0.6%+245,000NewHistory
GHRSGH Research PLCORDINARY SHARES499,400$9.13M0.6%00.0%UnchangedHistory
TNYATenaya Therapeutics, Inc.COM546,923$6.44M0.4%−215,394−28.3%ReducedHistory
ASMBAssembly Biosciences, Inc.COM3,000,000$6.18M0.4%00.0%UnchangedHistory
NUVBNuvation Bio Inc.COM CL A1,155,492$6.08M0.4%+1,155,492NewHistory
ATYRaTYR PHARMA INCCOM NEW1,028,515$5.50M0.4%−71,485−6.5%ReducedHistory
RLMDRelmada Therapeutics, Inc.COM102,117$2.76M0.2%+102,117NewHistory
VIGLVigil Neuroscience, Inc.COM389,141$2.74M0.2%+389,141NewHistory
VERVVerve Therapeutics, Inc.COM102,342$2.33M0.2%−397,658−79.5%ReducedHistory
AUTLAutolus Therapeutics plcSPON ADS382,559$1.59M0.1%+382,559NewHistory
RFLRafael Holdings, Inc.COM CL B104,156$261.0K<0.1%−181,558−63.5%ReducedHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q1 2022
SecurityClassPutsCalls
NKTRNektar TherapeuticsCOM$2.69M$5.39M
PTGXProtagonist Therapeutics, IncCOM$3.51M–

Sold out since Q4 2021 (11)

Positions held at the end of Q4 2021 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q4 2021
SecurityClassShares in Q4 2021Value in Q4 2021% of portfolio in Q4 2021History
Avidity Biosciences, Inc.05370A108COM1,000,000$23.8M1.8%–
KRTXKaruna Therapeutics, Inc.COM130,200$17.1M1.3%History
PTGXProtagonist Therapeutics, IncCOM421,660$14.4M1.1%History
SRRASierra Oncology, Inc.COM NEW607,600$13.2M1.0%History
ATRAAtara Biotherapeutics, Inc.COM750,000$11.8M0.9%History
ASNDAscendis Pharma A/SSPONSORED ADR80,000$10.8M0.8%History
VNDAVanda Pharmaceuticals Inc.COM500,000$7.84M0.6%History
CNTACentessa Pharmaceuticals plcSPONSORED ADS400,000$4.50M0.3%History
TECXTectonic Therapeutic, Inc.COM1,050,132$4.04M0.3%History
CNTBConnect Biopharma Holdings LtdADS647,057$3.33M0.2%History
ONCROncorus, Inc.COM600,000$3.16M0.2%History